The Elton John AIDS Foundation (EJAF) proudly announced nearly $1.6 million in grants to 26 organizations addressing the HIV/AIDS epidemic in critical and innovative ways. This final grant cycle brings EJAF’s total investments for 2017 to almost $9.5 million, and builds on the Foundation’s ongoing strategy to strengthen organizations doing essential work at local and national levels throughout the Americas and the Caribbean.
At a time when HIV transmission rates remain high for vulnerable populations, and funding for programs that advance the health and human rights of people affected by HIV/AIDS is being dramatically reduced, now is as critical time as ever to continue providing resources that help meet the needs of people affected by the disease.
In this grant-making cycle, EJAF is continuing to prioritize marginalized populations who often face significant barriers to care and resources and have a uniquely heightened risk of contracting HIV: LGBT people, Black people, HIV-positive people in the criminal justice system, sex workers, and young people in the United States and Puerto Rico, Colombia, Jamaica, and Mexico.
(Ad) Stop getting irritated with excessing advertisements. View the information you want quickly on a clean, ad-free and exclusive Member Dashboard that offers tools to search for grants, view latest grant opportunities, upcoming deadlines, sample proposals, downloadable ebooks and also organize your favourites! Learn more.
Sir Elton John created EJAF 25 years ago, first in the United States in 1992 and then in the United Kingdom in 1993. Through the generous support of far-sighted individuals, foundations, and corporations, the two foundations together have raised more than $400 million over the past quarter century to challenge discrimination against people affected by the epidemic, prevent infections, provide treatment and services, and motivate governments to end AIDS. The U.S. foundation focuses its efforts on programs in the United States, the Americas, and the Caribbean while the U.K. foundation funds HIV-related work in Europe, Asia, and Africa.